SIGA - SIGA Technologies hits 52-week high as monkeypox concern grows
- SIGA Technologies ( NASDAQ: SIGA ), buoyed by orders for its smallpox antiviral TPOXX (tecovirimat) being used for monkeypox as the number of cases continues to grow, hit a 52-week high of $16.34.
- The stock closed up 29% Monday. Year to date, it is up ~119%.
- Monday's dramatic rise is likely attributed to the July 23 WHO announcement that monkeypox is now a public health emergency of international concern .
- Earlier in July, SIGA ( SIGA ) said it received $28M in new contracts for TPOXX .
For further details see:
SIGA Technologies hits 52-week high as monkeypox concern grows